According to Vifor Pharma's latest financial reports the company's current earnings (TTM) are $0.35 B. In 2021 the company made an earning of $0.35 B an increase over its 2020 earnings that were of $0.30 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2021 | $0.35 B | 13.59% |
2020 | $0.30 B | -6.06% |
2019 | $0.32 B | 17.13% |
2018 | $0.28 B | 81.32% |
2017 | $0.15 B | -56.92% |
2016 | $0.35 B | -21.21% |
2015 | $0.45 B | 17.99% |
2014 | $0.38 B | -13.18% |
2013 | $0.44 B | 13.39% |
2012 | $0.39 B | 7.07% |
2011 | $0.36 B | 2.35% |
2010 | $0.35 B | 33.45% |
2009 | $0.26 B | -2.38% |
2008 | $0.27 B | 89.51% |
2007 | $0.14 B | 35.56% |
2006 | $0.10 B | 32.58% |
2005 | $80.78 M | -0.35% |
2004 | $81.06 M | -12.49% |
2003 | $92.63 M | -37.52% |
2002 | $0.14 B |